FDA commissioner calls for more onshoring of clinical trials

FDA Commissioner Robert Califf took to the stage twice in the last 12 hours in San Francisco, lining up his priorities and digging in on vaccine misinformation, accelerated approval reforms, and a renewed interest in onshoring more clinical trials where companies may be trying to save money, particularly in oncology.


Click to view original post